SEGMENT DISCLOSURES (Tables)

6 Months Ended

Jun. 30, 2022

SEGMENTED INFORMATION

Schedule Of Geographical Information Of Company's Non-current Assets

Thousands of United States dollars	Cannabis growth and derivative production			Consumer products			Pharmaceuticals and nutraceuticals		Beverage and food			Corporate and Eliminations			Total
For the six months ended June 30, 2022
Revenue	$	3		$	13,603		$	3,708	$	252		$	(2,649	)	$	14,917
Gross profit		47			4,304			2,096		99			-			6,546
Net (loss) income		(715	)		(19,420	)		317		(462	)		(12,436	)		(32,716	)
For the six months ended June 30, 2021
Revenue	$	-		$	286		$	1,629	$	310		$	(107	)	$	2,118
Gross profit		-			173			752		87			-			1,012
Net (loss) income		(428	)		(857	)		50		(64	)		(3,839	)		(5,138	)

Thousands of United States dollars	Colombia		United States		Canada		United Kingdom		Total
Non-current assets at June 30, 2022	$	5,320	$	42,351	$	1,533	$	2,708	$	51,912
Total liabilities at June 30, 2022		2,732		9,290		4,496		81		16,599
Non-current assets at December 31, 2021	$	4,042	$	29,650	$	3,844	$	-	$	37,536
Total liabilities at December 31, 2021		2,359		3,106		3,073		-		8,538
Six months ended June 30, 2022
Net revenue	$	1,631	$	12,887	$	-	$	399	$	14,917
Gross profit		999		5,471		-		76		6,546
Six Months Ended June 30, 2021
Net revenue	$	2,069	$	49	$	-	$	-	$	2,118
Gross profit		1,009		3		-		-		1,012